Position in LH
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,015,280
+$152,684 QoQ
Shares Held
3,626
+12.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#464
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026QRG CAPITAL MANAGEMENT, INC. holds $62,814,130 across 17 Diagnostics & Research names. LH ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
36,743 | $18,421,470 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
58,407 | $11,285,400 | |
| 3 | DHR |
Danaher Corp /De/
|
36,461 | $6,945,091 | |
| 4 | A |
Agilent Technologies, Inc.
|
49,576 | $6,585,180 | |
| 5 | DGX |
Quest Diagnostics Inc
|
25,798 | $5,467,886 | |
| 6 | NTRA |
Natera, Inc.
|
19,488 | $5,290,017 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
3,323 | $1,749,360 | |
| 8 | ILMN |
Illumina, Inc.
|
7,261 | $1,276,701 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,015,280 | 3,626 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $862,596 | 3,233 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $837,939 | 3,340 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $878,116 | 3,059 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $3,751,267 | 14,290 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $3,803,437 | 16,342 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $3,803,272 | 16,585 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,931,236 | 17,591 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $9,628,465 | 47,312 | Shares | Sole | 2024-07-12 | |
| No filing history on record for this holder in this stock. | ||||||